{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:01:05Z","timestamp":1790276465882,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jfo.2025.104751","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:03:32Z","timestamp":1767625412000},"page":"104751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of the ocular surface in rheumatoid arthritis patients on conventional synthetic disease-modifying antirheumatic drugs"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8622-507X","authenticated-orcid":false,"given":"K.","family":"Demir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7816-0627","authenticated-orcid":false,"given":"B.","family":"\u00c7ak\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Kahyao\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"G\u00f6n\u00fcll\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2025.104751_bib0095","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3390\/cells9040880","article-title":"Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis","volume":"9","author":"Lin","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jfo.2025.104751_bib0100","series-title":"Klinik Romatoloji","first-page":"269","article-title":"Ba\u011f Dokusu Hastal\u0131klar\u0131: Romatoid artrit","author":"G\u00fcm\u00fc\u015fdi\u015f","year":"1999"},{"key":"10.1016\/j.jfo.2025.104751_bib0105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.autrev.2011.09.001","article-title":"Extraarticular manifestations of rheumatoid arthritis: an update","volume":"11","author":"Prete","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jfo.2025.104751_bib0110","doi-asserted-by":"crossref","first-page":"323","DOI":"10.17305\/bjbms.2010.2680","article-title":"Ocular manifestation of rheumatoid arthritis-different forms and frequency","volume":"10","author":"Zlatanovi_c","year":"2010","journal-title":"Bosn J Basic Med Sci"},{"key":"10.1016\/j.jfo.2025.104751_bib0115","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nrrheum.2014.85","article-title":"The eye: a window of opportunity in rheumatoid arthritis?","volume":"10","author":"Tong","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jfo.2025.104751_bib0120","first-page":"393","article-title":"Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies","volume":"9","author":"Vignesh","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jfo.2025.104751_bib0125","doi-asserted-by":"crossref","first-page":"278","DOI":"10.5312\/wjo.v6.i2.278","article-title":"Is non-biological treatment of rheumatoid arthritis as good as biologics?","volume":"6","author":"Parida","year":"2015","journal-title":"World J Orthop"},{"key":"10.1016\/j.jfo.2025.104751_bib0130","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.intimp.2015.03.019","article-title":"Rheumatoid arthritis: biological therapy other than anti-TNF","volume":"27","author":"Rossi","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jfo.2025.104751_bib0135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/15569527.2016.1144193","article-title":"Ocular surface findings in patients with rheumatoid arthritis under methotrexate or biological agent therapy","volume":"36","author":"Sevimli","year":"2017","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.jfo.2025.104751_bib0140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.reuma.2017.07.020","article-title":"Systematic review and meta-analysis of the efficacy and safety of leflunomide and methotrexate in the treatment of rheumatoid arthritis","volume":"15","author":"Alfaro-Lara","year":"2019","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"10.1016\/j.jfo.2025.104751_bib0145","first-page":"393","article-title":"Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies","volume":"9","author":"Vignesh","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jfo.2025.104751_bib0150","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/1753425912461677","article-title":"In vivo confocal microscopic evaluation of corneal Langerhans cell density, and distribution and evaluation of dry eye in rheumatoid arthritis","volume":"19","author":"Marsovszky","year":"2013","journal-title":"Innate Immun"},{"key":"10.1016\/j.jfo.2025.104751_bib0155","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/1753425912471692","article-title":"Inflammation in dry eye associated with rheumatoid arthritis: cytokine and in vivo confocal microscopy study","volume":"19","author":"Villani","year":"2013","journal-title":"Innate Immun"},{"key":"10.1016\/j.jfo.2025.104751_bib0160","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000487487","article-title":"Meibomian gland dysfunction in primary and secondary Sj\u00f6gren syndrome","volume":"59","author":"Sullivan","year":"2018","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.jfo.2025.104751_bib0165","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s10067-014-2548-8","article-title":"The effect of leflunomide on the eye dryness in secondary Sj\u00f6gren's syndrome associated with rheumatoid arthritis and in rheumatoid arthritis patients","volume":"33","author":"Shahin","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jfo.2025.104751_bib0170","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3346\/jkms.2016.31.7.1127","article-title":"Effect of hydroxychloroquine treatment on dry eyes in subjects with primary Sj\u00f6gren's syndrome: a double-blind randomized control study","volume":"31","author":"Yoon","year":"2016","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jfo.2025.104751_bib0175","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/rheumatology\/kep104","article-title":"Treatment of sicca symptoms with hydroxychloroquine in patients with Sjogren's syndrome","volume":"48","author":"Rihl","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jfo.2025.104751_bib0180","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00296-010-1415-4","article-title":"Hydroxychloroquine improves dry eye symptoms of patients with primary Sjogren's syndrome","volume":"31","author":"Yavuz","year":"2011","journal-title":"Rheumatol Int"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018155122500333X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018155122500333X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T17:37:09Z","timestamp":1772300229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S018155122500333X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S018155122500333X"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2025.104751","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the ocular surface in rheumatoid arthritis patients on conventional synthetic disease-modifying antirheumatic drugs","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2025.104751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104751"}}